5lh8
From Proteopedia
(Difference between revisions)
m (Protected "5lh8" [edit=sysop:move=sysop]) |
|||
(2 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Trypsin inhibitors for the treatment of pancreatitis - cpd 8== | |
+ | <StructureSection load='5lh8' size='340' side='right'caption='[[5lh8]], [[Resolution|resolution]] 1.54Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[5lh8]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5LH8 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5LH8 FirstGlance]. <br> | ||
+ | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.54Å</td></tr> | ||
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=6WH:(2~{S},4~{S})-1-[4-(AMINOMETHYL)-3-METHOXY-PHENYL]CARBONYL-4-(4-CYCLOPROPYL-1,2,3-TRIAZOL-1-YL)-~{N}-[(1~{S},2~{R})-2-PHENYLCYCLOHEXYL]PYRROLIDINE-2-CARBOXAMIDE'>6WH</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5lh8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5lh8 OCA], [https://pdbe.org/5lh8 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5lh8 RCSB], [https://www.ebi.ac.uk/pdbsum/5lh8 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5lh8 ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/TRY1_BOVIN TRY1_BOVIN] | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Proline-based trypsin inhibitors occupying the S1-S2-S1' region were identified by an HTS screening campaign. It was discovered that truncation of the P1' moiety and appropriate extension into the S4 region led to highly potent trypsin inhibitors with excellent selectivity against related serine proteases and a favorable hERG profile. | ||
- | + | Trypsin inhibitors for the treatment of pancreatitis.,Brandl T, Simic O, Skaanderup PR, Namoto K, Berst F, Ehrhardt C, Schiering N, Mueller I, Woelcke J Bioorg Med Chem Lett. 2016 Jul 17. pii: S0960-894X(16)30742-9. doi:, 10.1016/j.bmcl.2016.07.029. PMID:27476144<ref>PMID:27476144</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | [[ | + | </div> |
- | [[Category: | + | <div class="pdbe-citations 5lh8" style="background-color:#fffaf0;"></div> |
- | [[Category: | + | |
- | [[Category: | + | ==See Also== |
- | [[Category: D'Arcy | + | *[[Trypsin 3D structures|Trypsin 3D structures]] |
- | [[Category: Schiering | + | == References == |
- | [[Category: Simic | + | <references/> |
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Bos taurus]] | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Brandl T]] | ||
+ | [[Category: D'Arcy A]] | ||
+ | [[Category: Schiering N]] | ||
+ | [[Category: Simic O]] | ||
+ | [[Category: Skaanderup P]] | ||
+ | [[Category: Woelcke J]] |
Current revision
Trypsin inhibitors for the treatment of pancreatitis - cpd 8
|
Categories: Bos taurus | Large Structures | Brandl T | D'Arcy A | Schiering N | Simic O | Skaanderup P | Woelcke J